Chih-Pin Chuu (Max)
- Previous affiliation: Postdoctoral Fellow in Dr. Richard Jones' lab
- Current Affiliation: Assistant Investigator, Institute of Cellular and System Medicine, National Health Research Institutes
National Health Research Institutes
35 Keyan Road
Zhunan, Miaoli County 35053, Taiwan
Max was involved in using protein array and high-throughput fluorescent polarization (FP) in studying the comprehensive interaction profile of human SH2 domain proteins and ErbB families, androgen receptor (AR), as well as other receptor tyrosine kinase (RTK)s. Max was also involved in the development of high-throughput Western blot technology (Micro-Western Array, MWA). Max used the MWA and other functional assays to study the anticancer activity of natural compound caffeic acid phenethyl ester in prostate cancer cells.
Currently, Max has established his lab in NHRI. Research of Chuu lab focuses on studying the downstream signaling network of AR and liver X receptor (LXR) and their role in prostate and colon cancer using systems biology methods.
- Systems analysis of EGF receptor signaling dynamics with microwestern arrays
- Comprehensive Binary Interaction Mapping of SH2 Domains via Fluorescence Polarization Reveals Novel
- Cholestane-3?, 5?, 6?-triol Suppresses Proliferation, Migration, and Invasion of Human Prostate
- Caffeic acid phenethyl ester suppresses the proliferation of human prostate cancer cells